trial
as of 2026-07-01Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia
NCTId NCT03497013
at a glance
— · Completed
Enrollment 64 (actual)
Sponsored by Suzhou Psychiatric Hospital
Primary completion 2020-08-11
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
64 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2017-07-31
Primary completion
2020-08-11
Eligibility
ALL · 18 Years · 70 Years
Interventions & indications
Drugs
Sponsors
Suzhou Psychiatric HospitalLead Sponsor
Investigators
1
Guangzhong Yin, MDStudy Chair
Sites
2 total
Suzhou, ChinaSuzhou, China
Facts & assertions
4 sourced
Enrollment
64
Phase
NA
Primary Completion Date
2020-08-11
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
indication
investigator
person